NGL FINECHEM
|
The Current P/S Ratio of NGL FINECHEM is 2.36.
Share Price | ₹1,451.0 | Sep 02,2025 |
Market Cap | ₹899.6 Cr | |
Sales-TTM | ₹381.7 Cr | TTM-Consolidated Results |
Price/Sales | 2.36x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of NGL FINECHEM
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹899.6 Cr] as on Sep 02,2025
(/) Sales [ ₹381.7 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.36x ]
Thus, for NGL FINECHEM , the investors are currently willing to pay '2.36 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NGL FINECHEM !
The chart below summarizes the trend in P/S Ratio of NGL FINECHEM over the last five years.
Historical PS (Price/Sales) ratio chart of NGL FINECHEM
PS Ratio Performance Analysis for NGL FINECHEM
- NGL FINECHEM 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.16x.
- NGL FINECHEM 's operated at median p/e ratio of 3.67x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/e ratio peaked in Mar2024 at 3.81x.
- NGL FINECHEM 's p/e ratio hit its five-year low in Mar2025 of 1.87x.
How does NGL FINECHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
NGL FINECHEM | 381.7 | 2.36 | 899.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 6.98 | 375,388.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.84 | 162,513.0 |
CIPLA LTD | 27,811.2 | 4.56 | 126,733.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.25 | 121,292.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.13 | 104,935.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.10 | 104,964.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.25 | 100,241.0 |
LUPIN LTD | 23,375.9 | 3.69 | 86,278.6 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.85 | 59,323.1 |
ABBOTT INDIA LTD | 6,589.9 | 10.43 | 68,754.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NGL FINECHEM 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.85x |
Max industry PS | 16.84x |
Median industry PS | 4.56x |
Average industry PS | 6.59x |
You may also like the below Video Courses